Gentian is a company listed on Euronext Oslo Børs as GENT.
Latest share price development, trade volumes and other share information can be found on Euronext.
30.04.2023
Shareholder | No of Shares | % |
Vatne Equity AS | 2 110 224 | 13.68 % |
Kvantia AS | 1 623 368 | 10.53 % |
Holta Life Sciences AS | 1 214 702 | 7.88 % |
Verdipapirfondet Delphi Nordic | 987 104 | 6.40 % |
Safrino AS | 749 700 | 4.86 % |
Carpe Diem Afseth AS | 531 589 | 3.45 % |
Skandinaviska Enskilda Banken AB | 499 315 | 3.24 % |
Verdipapirfondet DNB SMB | 361 291 | 2.34 % |
Verdipapirfondet Storebrand Vekst | 331 220 | 2.15 % |
J.P. Morgan SE | 325 000 | 2.11 % |
Portia AS | 300 000 | 1.95 % |
Intertrade Shipping AS | 257 716 | 1.67 % |
Cressida AS | 235 000 | 1.52 % |
Verdipapirfondet Equinor Aksjer NO | 227 880 | 1.48 % |
Lioness AS | 220 000 | 1.43 % |
Krefting, Johan Henrik | 213 700 | 1.39 % |
Marstal AS | 212 407 | 1.38 % |
Mutus AS | 210 465 | 1.36 % |
Salix AS | 208 954 | 1.35 % |
Vingulmork Predictor AS | 184 083 | 1.19 % |
Other Shareholders | 4 418 632 | 28.65 % |
Total Shares | 15 422 350 | 100 % |
Name and position of primary insiders can be found on Euronext.
Njaal Kind
CFO, Gentian Diagnostics ASA
njaal.kind@gentian.com
+47 91906525